Bildkälla: Stockfoto

Vitrolife ahead of Q3: We expect Vitrolife to extend the consolidation period - Redeye

Vitrolife is going through a period with softer organic growth in the 3-6% which compares with a more typical 8-11% strict organic growth for Vitrolife, in our view. Consumables are likely to perform, and the main uncertainty and also our main near-term interest relates to Genetic Services and Vitrolife’s ability to stabilize and improve the growth rate.

Vitrolife is going through a period with softer organic growth in the 3-6% which compares with a more typical 8-11% strict organic growth for Vitrolife, in our view. Consumables are likely to perform, and the main uncertainty and also our main near-term interest relates to Genetic Services and Vitrolife’s ability to stabilize and improve the growth rate.
Börsvärldens nyhetsbrev
ANNONSER